Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
Advertisement
Articles by Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
Advertisement
Latest Updated Articles
Targeted Treatment Options in Multiple MyelomaAugust 10th 2020
The Future of Multiple MyelomaAugust 10th 2020
A Look at the ENDURANCE TrialAugust 10th 2020
Maintenance Therapy in Multiple MyelomaAugust 10th 2020
Treatment Options in Relapsed/Refractory Multiple MyelomaAugust 10th 2020
Trials in Relapsed/Refractory Multiple MyelomaAugust 10th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC
2
Ivonescimab Plus Chemotherapy Sustains OS Benefit Across Western and Asian Patients in Pretreated EGFR-Mutated NSCLC
3
NMPA Accepts Toripalimab Plus Chemotherapy Application for Expanded Stage II-III NSCLC Use
4
Dr Hoffmann on the Significance of Efficacy Data for Sonrotoclax Plus Zanubrutinib in MCL
5